New DNA ‘Fingerprint’ Test Predicts Response To Toxic Breast Cancer Drugs
Scientists have developed a new genetic fingerprint test which aims to identify women with breast cancer who are likely to respond to a class of often-useful, but toxic chemotherapy agents including one commonly referred to as " the red devil " by patients and survivors.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Genetics | Pharmaceuticals | Toxicology | Women